by Darryl | May 9, 2025 | Steroids
Hoy SM. Contezolid: first approval. Drugs. 2021;81:1587–91.Article PubMed PubMed Central Google Scholar Zhang GXZ, et al. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment. Infection. 2024;52:787–800.Article PubMed Google...
by Darryl | May 7, 2025 | Steroids
Lascufloxacin (LSFX) is a novel quinolone antibiotic characterized by its concentration in lung epithelial lining fluid (ELF), which is 15.0–22.4 times higher than in blood and 18.5–56.4 times higher in alveolar macrophages [1, 2]. These properties make LSFX a...
by Darryl | May 7, 2025 | Steroids
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet D, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318–27.Article PubMed Google...
by Darryl | Apr 24, 2025 | Steroids
Schroers HJ. A monograph of Bionectria (Ascomycota, Hypocreales, Bionectriaceae) and its Clonostachys anamorphs. Stud Mycol. 2001;46:1–214. Google Scholar Chen WH, Han YF, Liang JD, Zou X, Liang ZQ, Jin DC. A new araneogenous fungus of the genus Clonostachys....
by Darryl | Apr 23, 2025 | Steroids
Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet. 2022;399:629–55.Article CAS Google Scholar WHO bacterial priority pathogens list, 2024:...
